Canadian Guideline Homes In On Excessive Medicine Pricing
New draft guidelines outlining how Canada’s drug pricing authority will decide whether to investigate if a medicine is excessively priced are now out for consultation.
You may also be interested in...
Provisional guidance on controversial pricing reforms is now in place in Canada.
Some measures aimed at reducing medicine prices in Canada have been dropped, to the relief of the pharmaceutical industry.
ANVISA, Brazil’s medicines regulator, is asking for feedback on the regulatory pathway for biosimilars.